Management of biliary tract disease during pregnancy: a decision analysis.
BACKGROUND
The appropriate management of biliary tract disease during pregnancy is uncertain. Although laparoscopic cholecystectomy can be performed safely during pregnancy, the timing and indications for this surgical intervention have not been firmly established.


METHODS
We constructed a Markov decision analytic model that incorporates maternal well-being and fetal outcome into a choice between nonoperative management (NM) and laparoscopic cholecystectomy (LC) for pregnant women with biliary tract disease (BTD). Our model cycles through weeks of pregnancy for a cohort of 200 gravid women presenting with biliary tract disease in both the first and second trimesters. Weekly state probabilities and utilities for fetal outcome were derived from the literature, while weekly utilities for disease and operative states were estimated in consultation with obstetricians. We cycled the model from 6 to 42 weeks and from 19 to 42 weeks to simulate first and second trimester presentations. Outcomes are expressed in quality pregnancy weeks (QPWs). One QPW is the utility of a normal healthy week of pregnancy.


RESULTS
A comprehensive search of the literature yielded a fetal death rate following LC for biliary tract disease of 2.2% and following NM of 7%. Relapse rates were found to be trimester dependent and estimated to be 55%, 55%, and 40% in the first, second, and third trimester, respectively. For a hypothetical cohort of 100 women presenting with biliary tract disease in their first trimester, LC generated 12,800 QPWs compared with 12,400 QPWs for NM, an average gain of 4 QPWs per woman. For the cohort of women entering the model in the second trimester, 11,600 QPWs were accrued by the LC group and 11,400 QPWs by the NM group, an average gain of 2 QPWs per woman. These findings were sensitive only to changes in fetal death rates under the two treatment arms.


CONCLUSIONS
Laparoscopic cholecystectomy is superior to nonoperative management for pregnant women presenting in the first or second trimester with biliary tract disease.
Jelin
Eric B
EB
Department of Surgery, University of California San Francisco, San Francisco, CA, USA. Eric.Jelin@ucsfmedctr.org
Smink
Douglas S
DS
Vernon
Ashley H
AH
Brooks
David C
DC
D000328:Adult; D001660:Biliary Tract Diseases / Q000175:diagnosis / Q000601:surgery*; D016022:Case-Control Studies; D017081:Cholecystectomy, Laparoscopic / Q000009:adverse effects / Q000379:methods*; D015331:Cohort Studies; D003661:Decision Support Techniques; D005260:Female; D047109:Fetal Development / Q000502:physiology; D046689:Fetal Mortality / Q000639:trends*; D005500:Follow-Up Studies; D006801:Humans; D008390:Markov Chains; D015999:Multivariate Analysis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000601:surgery*; D011256:Pregnancy Outcome; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D011296:Prenatal Diagnosis / Q000379:methods; D012016:Reference Values; D018570:Risk Assessment
Am J Surg. 1993 May;165(5):625-7
8488949
Am Surg. 1978 Jul;44(7):432-4
686528
Am J Obstet Gynecol. 1989 Nov;161(5):1178-85
2589435
Am J Surg. 1987 Sep;154(3):292-4
3631407
Surg Endosc. 1995 Aug;9(8):910-3
8525447
Am Surg. 1999 Mar;65(3):259-63
10075305
Obstet Gynecol. 1975 Sep;46(3):291-3
1161232
Am J Surg. 1999 Dec;178(6):545-8
10670869
Surg Gynecol Obstet. 1992 Jun;174(6):465-8
1595022
Med Decis Making. 1997 Apr-Jun;17(2):123-5
9107606
N Engl J Med. 1950 Jan 25;244(4):128-31
14796797
Surg Endosc. 1992 May-Jun;6(3):115-7
1386945
Am Surg. 1996 Oct;62(10):874-7
8813175
Surg Endosc. 1997 Dec;11(12):1216-7
9373298
Anesthesiology. 1996 Dec;85(6):1395-402
8968187
Br J Obstet Gynaecol. 1998 Feb;105(2):169-73
9501781
Surg Laparosc Endosc. 1991 Sep;1(3):193-4
1669402
Surg Laparosc Endosc. 1993 Feb;3(1):13-6
8258063
Med Decis Making. 1997 Apr-Jun;17(2):142-51
9107609
J Reprod Med. 1995 Nov;40(11):759-62
8592309
Am J Surg. 1994 Dec;168(6):576-9; discussion 580-1
7977999
Obstet Gynecol. 1991 Nov;78(5 Pt 2):958-9
1833689
Am J Surg. 1986 Feb;151(2):263-5
3511761
J Reprod Med. 1995 Mar;40(3):243-5
7776316
Am Surg. 1998 Jan;64(1):93-7; discussion 97-8
9457045
Surg Endosc. 1997 Feb;11(2):98-102
9069135
Surg Endosc. 2000 Mar;14 (3):267-71
10741447
Am Surg. 2001 Jun;67(6):539-42; discussion 542-3
11409801
J Laparoendosc Surg. 1993 Jun;3(3):291-3
8347888
Surg Laparosc Endosc. 1994 Feb;4(1):65-7
8167871
Surg Laparosc Endosc. 1994 Aug;4(4):268-71
7952436
Am J Surg. 1999 Dec;178(6):523-9
10670865
Surg Endosc. 1994 Jul;8(7):794-6
7974110
Surg Endosc. 1996 May;10(5):508-10
8658328
Am J Surg. 2004 Dec;188(6):755-9
15619495
Surg Endosc. 1998 Mar;12(3):241-6
9502704
Med Decis Making. 1997 Apr-Jun;17(2):152-9
9107610
Med Decis Making. 1997 Apr-Jun;17(2):126-35
9107607
Surgery. 1992 Nov;112(5):856-9
1440236
Surg Endosc. 1996 May;10(5):511-5
8658329
Surg Laparosc Endosc. 1994 Feb;4(1):68-9
8167872
Surg Endosc. 2004 Feb;18(2):237-41
14691706
J Am Coll Surg. 1997 Jun;184(6):589-95
9179115
J Ark Med Soc. 1993 Jan;89(8):383-4
8428847
Arch Surg. 1996 May;131(5):546-50; discussion 550-1
8624203
Med Decis Making. 1997 Apr-Jun;17(2):136-41
9107608
Surgery. 1995 Oct;118(4):627-31; discussion 631-3
7570315
J Reprod Med. 1993 Oct;38(10):833-4
8263879
Am J Surg. 1999 Mar;177(3):232-6
10219860
Surg Laparosc Endosc. 1996 Dec;6(6):441-4
8948035
Am J Surg. 1996 Apr;171(4):435-7
8604838
Obstet Gynecol Surv. 1998 Sep;53(9):566-74
9751939
Surg Endosc. 1997 Jan;11(1):15-8
8994981
J Laparoendosc Surg. 1994 Apr;4(2):161-4
8043927
Am J Obstet Gynecol. 1991 Aug;165(2):401-2
1831323
J Laparoendosc Surg. 1993 Feb;3(1):35-9
8453126
Aust N Z J Surg. 1994 Sep;64(9):647-9
8085985